ARE DRUG FIRMS DISEASE-MONGERING?

Are CME providers being used by the pharmaceutical industry to legitimize a treatment for conditions that aren't really diseases? Did Glaxo SmithKline “invent” irritable bowel syndrome in part by underwriting CME on the subject? These uncomfortable questions have been raised in an article in the April 13 issue of BMJ (formerly known as the British Medical Journal).

In “Selling Sickness: The Pharmaceutical Industry and Disease Mongering,” authors Ray Moynihan, a journalis

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Already a member? .

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish